Patient Identification for Phase II Arthritis Drug Study in US & Europe

February 9, 2018

Challenge

Launch the project at an investigator meeting in Europe ten days after contract signing. Complete as many randomizations as possible in this 140-subject study with extremely narrow inclusion criteria by using only “in-practice” patients within the sites’ databases or that of their referring physicians.

Solution

Implemented our ThreeWire Chart Review™ services at selected sites in eastern and western Europe, UK, Canada and the US. Candidates identified were contacted either via telephone or letter and offered the opportunity to screen for the study.

Results

Thousands of patient charts were reviewed to identify over 300 potential participants. Approximately 180 were evaluated for suitability for site screening, resulting in 50 site screening visits and 35 randomizations. Project completed in 90 days.

“I have to say, you sure have a great team at ThreeWire! Everyone should be so lucky!”
- Study Project Manager Top 10 Pharma Company

Previous Flipbook
Patient Recruitment for Obesity Implant Device Study
Patient Recruitment for Obesity Implant Device Study

The sponsor needed to complete enrollment in less than six months to meet the enrollment goal of randomized...

Next Flipbook
Patient Enrollment for Neurostimulation Device Study
Patient Enrollment for Neurostimulation Device Study

Challenge: meet time-sensitive enrollment goal of 496 patients in order to extend labeling for FDA-approved...